Terms: = Lung cancer AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era AND Staging
3604 results:
1. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Interstitial Pneumonia Induced by Immune Checkpoint Inhibitors for Gastric cancer During the COVID- 19 Pandemic].
Yasuda K; Naito M; Kawakami K; Kishimoto A; Narita K; Moriwaki Y; Otani J
Gan To Kagaku Ryoho; 2024 Apr; 51(4):466-469. PubMed ID: 38644324
[TBL] [Abstract] [Full Text] [Related]
3. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA.
Wang H; Wang J; Liu Y; Wang Y; Zhou Y; Yu D; You H; Ren T; Tang Y; Wang M
Diagn Pathol; 2024 Apr; 19(1):61. PubMed ID: 38641621
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
5. The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system.
Wang Y; Fang L; Hu X; Wu H; Zhou L; Xue Q; Gao S; He J
J Cardiothorac Surg; 2024 Apr; 19(1):200. PubMed ID: 38600565
[TBL] [Abstract] [Full Text] [Related]
6. Alectinib in Resected
Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
[TBL] [Abstract] [Full Text] [Related]
7. High risk of lung cancer in surfactant-related gene variant carriers.
Brudon A; Legendre M; Mageau A; Bermudez J; Bonniaud P; Bouvry D; Cadranel J; Cazes A; Crestani B; Dégot T; Delestrain C; Diesler R; Epaud R; Philippot Q; Théou-Anton N; Kannengiesser C; Ba I; Debray MP; Fanen P; Manali E; Papiris S; Nathan N; Amselem S; Gondouin A; Guillaumot A; Andréjak C; Jouneau S; Beltramo G; Uzunhan Y; Galodé F; Westeel V; Mehdaoui A; Hirschi S; Leroy S; Marchand-Adam S; Nunes H; Picard C; Prévot G; Reynaud-Gaubert M; De Vuyst P; Wemeau L; Defossez G; Zalcman G; Cottin V; Borie R;
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38575158
[TBL] [Abstract] [Full Text] [Related]
8. Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals
Zhong C; Guo YE; Yang Q; Song Y; Wang T; Cai B; Chen H; Du H; Wan J; Liu Y; Li Y; Wan X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):100. PubMed ID: 38538277
[TBL] [Abstract] [Full Text] [Related]
9. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Xie M; Gao J; Ma X; Song J; Wu C; Zhou Y; Jiang T; Liang Y; Yang C; Bao X; Zhang X; Yao J; Jing Y; Wu J; Wang J; Xue X
BMC Cancer; 2024 Mar; 24(1):372. PubMed ID: 38528507
[TBL] [Abstract] [Full Text] [Related]
10. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
[TBL] [Abstract] [Full Text] [Related]
11. [Introduction to the 9
Zhang B; Fang WT; Zhong H
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):206-210. PubMed ID: 38494767
[TBL] [Abstract] [Full Text] [Related]
12. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
[TBL] [Abstract] [Full Text] [Related]
13. lung cancer Diagnoses and Outcomes During the Syrian War, 2011-2018.
Hanafi I; Abo Samra D; Alsaqqa R; Naeem A; Shebli B; Ajlyakin G
JAMA Netw Open; 2024 Mar; 7(3):e242091. PubMed ID: 38477917
[TBL] [Abstract] [Full Text] [Related]
14. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.
Salehjahromi M; Karpinets TV; Sujit SJ; Qayati M; Chen P; Aminu M; Saad MB; Bandyopadhyay R; Hong L; Sheshadri A; Lin J; Antonoff MB; Sepesi B; Ostrin EJ; Toumazis I; Huang P; Cheng C; Cascone T; Vokes NI; Behrens C; Siewerdsen JH; Hazle JD; Chang JY; Zhang J; Lu Y; Godoy MCB; Chung C; Jaffray D; Wistuba I; Lee JJ; Vaporciyan AA; Gibbons DL; Gladish G; Heymach JV; Wu CC; Zhang J; Wu J
Cell Rep Med; 2024 Mar; 5(3):101463. PubMed ID: 38471502
[TBL] [Abstract] [Full Text] [Related]
15. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in lung cancer Radiotherapy.
Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
[TBL] [Abstract] [Full Text] [Related]
16. Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.
Wang RR; Li MJ; Peng Q; Huang ZY; Wu LL; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38426334
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the multifaceted effects of Interleukin-1 in lung cancer: From tumor development to immune modulation.
Tang M; Yin Y; Wang W; Gong K; Dong J; Gao X; Li J; Fang L; Ma J; Hong Y; Li Z; Bi T; Zhang W; Liu W
Life Sci; 2024 Apr; 342():122539. PubMed ID: 38423172
[TBL] [Abstract] [Full Text] [Related]
18. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
[TBL] [Abstract] [Full Text] [Related]
19. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
[TBL] [Abstract] [Full Text] [Related]
20. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
[TBL] [Abstract] [Full Text] [Related]
[Next]
